Roundhill GLP-1 & Weight Loss ETF (NQ: OZEM )

27.69 -0.80 (-2.81%)

Official Closing Price Updated: 4:15 PM EDT, Jul 17, 2024 Add to My Watchlist

Price and Volume

Volume	69,516
Open	27.87
Bid (Size)	27.27 (1)
Ask (Size)	28.11 (10)
Prev. Close	28.49
Today's Range	27.61 - 27.94
52wk Range	24.51 - 28.66
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential

June 07, 2024

New ETFs focusing on weight-loss drugs have launched. However, industry observers caution about their long-term prospects and the concentrated risks associated with these investments.

Via Benzinga

New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk

May 30, 2024

New OZEM ETF offers investors exposure to weight-loss sector through top pharmaceutical companies Eli Lilly and Novo Nordisk, with potential for high growth but also risks.

Via Benzinga

Performance

YTD	+9.14%	+9.14%
1 Month	+6.69%	+6.69%
3 Month	+9.14%	+9.14%
6 Month	+9.14%	+9.14%
1 Year	+9.14%	+9.14%

More News

Tesla (TSLA) Stock Drops as Glass Lewis Urges Against Elon Musk’s Pay Package

May 28, 2024

Via InvestorPlace

Campbell Soup Layoffs 2024: What to Know About New Campbell Job Cuts

May 28, 2024

Via InvestorPlace

OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF

May 28, 2024

Via InvestorPlace

South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next

May 23, 2024

Via Benzinga

EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic

May 21, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.